Channels - Comparison of Ideal vs. Actual Body Weight Dosing of Intravenous Immunoglobulins for Immune Thrombocytopenia: A Retrospective Analysis :: FRELIP Discovery

Similar Items: Comparison of Ideal vs. Actual Body Weight Dosing of Intravenous Immunoglobulins for Immune Thrombocytopenia: A Retrospective Analysis

Quick Look
A Rare Case Report of Immunoglobulin D Subtype Multiple Myeloma Complicated With Hyperlipidemia
Quick Look
Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
Quick Look
Unmasking Evans Syndrome: A Case of New Onset Anemia and Thrombocytopenia in a Pregnant Patient With Systemic Lupus Erythematosus
Quick Look
Real‐World vs. Randomized Trial Evidence for Incretin‐Based Therapies: A Narrative Review
Quick Look
Curing acute promyelocytic leukemia: no boost from immunity needed
Quick Look
Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Quick Look
Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis
Quick Look
Prevalence and Severity of Coronary Artery Calcification Assessed by Low‐Dose Computed Tomography in Individuals With Type 2 Diabetes With and Without Diabetic Foot: A Cross‐Sectional Study
Quick Look
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Quick Look
Body mass index and peripheral neuropathy across the glucose tolerance spectrum in Japanese adults
Quick Look
Triglyceride-glucose index as a predictor of body composition changes in patients undergoing bariatric surgery
Quick Look
A Retrospective Study of Infections and Antibiotic Susceptibility in Diabetic Foot Ulcers
Quick Look
Systematic Literature Review of the Economic and Quality of Life Burden of Congenital and Immune-Mediated Thrombotic Thrombocytopenic Purpura
Quick Look
Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMSlike tyrosine kinase 3 internal tandem duplication
Quick Look
Relative contributions of basal vs postprandial hyperglycaemia to overall glycaemic control in newly diagnosed Chinese adults with type 2 diabetes before and after 3 months' intensive glucose‐lowering therapy
Quick Look
Comparison between liraglutide and dulaglutide on the incidence or progression of eye and kidney complications
Quick Look
Extracellular water to total body water ratio as a predictor of all-cause mortality in type 2 diabetes
Quick Look
Hyper-CVAD in Adults With Acute Lymphoblastic Leukemia in Ecuador: A Multicenter Retrospective Study
Quick Look
Lipid metabolism profiles as predictors of gestational diabetes mellitus risk: A retrospective study
Quick Look
A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD)
Quick Look
Multiple Myeloma and Secondary Immunodeficiency: A Retrospective Database Analysis Assessing Burden of Infection and Treatment Patterns
Quick Look
Real-World Effectiveness of Tirzepatide in Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study
Quick Look
Association between blood pressure levels and mortality in patients with type 2 diabetes: A retrospective cohort analysis
Quick Look
Impact of COVID‐19 restrictions and their relaxation on body composition and glycemic control in individuals with glucose intolerance in Japan: A single‐center observational study